Prenetics Global Limited
NASDAQ Global MarketTotal Valuation
Prenetics Global Limited carries a market capitalization of 297.34M, placing it among publicly traded companies globally. Its enterprise value stands at 178.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 297.34M |
| Enterprise Value | 178.50M |
Share Statistics
Prenetics Global Limited currently has 16.73M shares outstanding.
| Shares Outstanding | 16.73M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.50, and the price-to-book ratio stands at 11,366.67.
| PE Ratio | N/A |
| PS Ratio | 2.50 |
| PB Ratio | 11,366.67 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | -16.33 |
| P/OCF Ratio | -16.33 |
Enterprise Valuation
| EV / Sales | 1.57 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Prenetics Global Limited maintains a current ratio of 5.15, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.38, indicating conservative leverage, while an interest coverage ratio of -227.45 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.15 |
| Quick Ratio | 4.60 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -227.45 |
Financial Efficiency
| Return on Equity (ROE) | -224,102.22 |
| Return on Assets (ROA) | -26.59 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.57 |
Taxes
| Income Tax | 42,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Prenetics Global Limited's stock has gained approximately 118.35206% over the past 52 weeks. The 50-day moving average sits at 18.43, while the 200-day moving average is 16.91.
| Beta (5Y) | N/A |
| 52-Week Price Change | 118.35206% |
| 50-Day Moving Average | 18.43 |
| 200-Day Moving Average | 16.91 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Prenetics Global Limited generated 113.75M in revenue and converted that into -50.42M in net income, yielding earnings per share of -3.72. EBITDA reached -37.53M, while operating income came in at -39.27M.
| Revenue | 113.75M |
| Gross Profit | 66.18M |
| Operating Income | -39.27M |
| Pretax Income | -54.70M |
| Net Income | -50.42M |
| EBITDA | -37.53M |
| EBIT | -39.27M |
| Earnings Per Share (EPS) | -3.72 |
Balance Sheet
Prenetics Global Limited holds 106.04M in cash and equivalents against 457,000.00 in total debt, resulting in a net debt position of -56.02M. Total book value stands at 25,000.00, with working capital of 106.47M providing operational flexibility.
| Cash & Cash Equivalents | 106.04M |
| Total Debt | 457,000.00 |
| Net Debt | -56.02M |
| Equity (Book Value) | 25,000.00 |
| Book Value Per Share | 0.00 |
| Working Capital | 106.47M |
Cash Flow
Prenetics Global Limited produced -17.40M in operating cash flow over the past twelve months.
| Operating Cash Flow | -17.40M |
| Capital Expenditures | N/A |
| Free Cash Flow | -17.40M |
| FCF Per Share | -1.18 |
Margins
Prenetics Global Limited operates with a gross margin of 58.19, reflecting its pricing power and cost economics. The operating margin of -34.52 and net profit margin of -44.33 provide insight into operational efficiency.
| Gross Margin | 58.19 |
| Operating Margin | -34.52 |
| Pretax Margin | -48.09 |
| Profit Margin | -44.33 |
| EBITDA Margin | -32.99 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.90 |
| FCF Yield | -6.12 |
Stock Splits
Prenetics Global Limited's most recent stock split took place on November 14, 2023 with a 15:1 split ratio.
| Last Split Date | 11/14/2023 |
| Split Ratio | 15:1 |
Scores
Prenetics Global Limited posts an Altman Z-Score of 3.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.78 |